Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Carl E Ruby

Showing results (21-30 of 27) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 27 results.
Cancer Cell International|May 2, 2021
Exosomal proteomic signatures correlate with drug resistance and carboplatin treatment outcome in a spontaneous model of canine osteosarcomaMarcus A Weinman, Stephen A Ramsey, Haley J Leeper, et al.
Veterinary Sciences|July 25, 2025
Characterization of a Potential Therapeutic Anti-Canine PD-1 Single Domain Antibody Produced in YeastKartikeya Vijayasimha, Andrew J Annalora, Dan V Mourich, et al.
Experimental Cell Research|July 18, 2017
Exosomes from Osteosarcoma and normal osteoblast differ in proteomic cargo and immunomodulatory effects on T cellsRyan M Troyer, Carl E Ruby, Cheri P Goodall, et al.
Cell Host & Microbe|November 17, 2007
HIV-1 Nef assembles a Src family kinase-ZAP-70/Syk-PI3K cascade to downregulate cell-surface MHC-IChien-Hui Hung, Laurel Thomas, Carl E Ruby, et al.
Translational Oncology|July 28, 2018
A Preliminary Proteomic Investigation of Circulating Exosomes and Discovery of Biomarkers Associated with the Progression of Osteosarcoma in a Clinical Model of Spontaneous DiseaseJacqueline V Brady, Ryan M Troyer, Stephen A Ramsey, et al.
Seminars in Oncology|November 16, 2010
Signaling through OX40 enhances antitumor immunityShawn M Jensen, Levi D Maston, Michael J Gough, et al.
Journal for Immunotherapy of Cancer|May 21, 2015
NK cells and CD8+ T cells cooperate to improve therapeutic responses in melanoma treated with interleukin-2 (IL-2) and CTLA-4 blockadeFrederick J Kohlhapp, Joseph R Broucek, Tasha Hughes, et al.
Pageof 3

Showing results (21-30 of 27) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 27 results.
Cancer Cell International|May 2, 2021
Exosomal proteomic signatures correlate with drug resistance and carboplatin treatment outcome in a spontaneous model of canine osteosarcomaMarcus A Weinman, Stephen A Ramsey, Haley J Leeper, et al.
Veterinary Sciences|July 25, 2025
Characterization of a Potential Therapeutic Anti-Canine PD-1 Single Domain Antibody Produced in YeastKartikeya Vijayasimha, Andrew J Annalora, Dan V Mourich, et al.
Experimental Cell Research|July 18, 2017
Exosomes from Osteosarcoma and normal osteoblast differ in proteomic cargo and immunomodulatory effects on T cellsRyan M Troyer, Carl E Ruby, Cheri P Goodall, et al.
Cell Host & Microbe|November 17, 2007
HIV-1 Nef assembles a Src family kinase-ZAP-70/Syk-PI3K cascade to downregulate cell-surface MHC-IChien-Hui Hung, Laurel Thomas, Carl E Ruby, et al.
Translational Oncology|July 28, 2018
A Preliminary Proteomic Investigation of Circulating Exosomes and Discovery of Biomarkers Associated with the Progression of Osteosarcoma in a Clinical Model of Spontaneous DiseaseJacqueline V Brady, Ryan M Troyer, Stephen A Ramsey, et al.
Seminars in Oncology|November 16, 2010
Signaling through OX40 enhances antitumor immunityShawn M Jensen, Levi D Maston, Michael J Gough, et al.
Journal for Immunotherapy of Cancer|May 21, 2015
NK cells and CD8+ T cells cooperate to improve therapeutic responses in melanoma treated with interleukin-2 (IL-2) and CTLA-4 blockadeFrederick J Kohlhapp, Joseph R Broucek, Tasha Hughes, et al.
Pageof 3